1. Home
  2. MIDD vs NUVL Comparison

MIDD vs NUVL Comparison

Compare MIDD & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIDD
  • NUVL
  • Stock Information
  • Founded
  • MIDD 1888
  • NUVL 2017
  • Country
  • MIDD United States
  • NUVL United States
  • Employees
  • MIDD N/A
  • NUVL N/A
  • Industry
  • MIDD Industrial Machinery/Components
  • NUVL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MIDD Industrials
  • NUVL Health Care
  • Exchange
  • MIDD Nasdaq
  • NUVL Nasdaq
  • Market Cap
  • MIDD 6.7B
  • NUVL 5.8B
  • IPO Year
  • MIDD N/A
  • NUVL 2021
  • Fundamental
  • Price
  • MIDD $138.60
  • NUVL $84.22
  • Analyst Decision
  • MIDD Buy
  • NUVL Strong Buy
  • Analyst Count
  • MIDD 8
  • NUVL 10
  • Target Price
  • MIDD $163.75
  • NUVL $119.50
  • AVG Volume (30 Days)
  • MIDD 665.8K
  • NUVL 408.2K
  • Earning Date
  • MIDD 10-30-2025
  • NUVL 11-11-2025
  • Dividend Yield
  • MIDD N/A
  • NUVL N/A
  • EPS Growth
  • MIDD 9.96
  • NUVL N/A
  • EPS
  • MIDD 7.86
  • NUVL N/A
  • Revenue
  • MIDD $3,841,176,000.00
  • NUVL N/A
  • Revenue This Year
  • MIDD $1.34
  • NUVL N/A
  • Revenue Next Year
  • MIDD $3.85
  • NUVL N/A
  • P/E Ratio
  • MIDD $17.63
  • NUVL N/A
  • Revenue Growth
  • MIDD N/A
  • NUVL N/A
  • 52 Week Low
  • MIDD $118.09
  • NUVL $55.54
  • 52 Week High
  • MIDD $182.73
  • NUVL $106.32
  • Technical
  • Relative Strength Index (RSI)
  • MIDD 57.03
  • NUVL 57.72
  • Support Level
  • MIDD $131.10
  • NUVL $81.02
  • Resistance Level
  • MIDD $134.44
  • NUVL $87.90
  • Average True Range (ATR)
  • MIDD 2.96
  • NUVL 3.70
  • MACD
  • MIDD 0.43
  • NUVL 0.45
  • Stochastic Oscillator
  • MIDD 82.37
  • NUVL 71.05

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: